CCL2 and pancreatic neoplasm: Independently, CCL2 was reported to recruit monocytes and reduce CD8+ T cell infiltration in pancreatic tumors, and CCL2 inhibition and monocyte neutralisation increased the sensitivity of PDAC to immune checkpoint blockade [14].